-
公开(公告)号:US20250075188A1
公开(公告)日:2025-03-06
申请号:US18899875
申请日:2024-09-27
Applicant: The University of Queensland
Inventor: Minoru Takasato , Melissa Little
Abstract: A method is provided for producing renal organoids comprising nephrons, ureteric bud and vasculature and/or progenitors of these. In one embodiment, the methods includes contacting intermediate mesoderm cells with: fibroblast growth factor 9 and/or fibroblast growth factor 20 and/or fibroblast growth factor 2 and optionally, one or more selected from the group consisting of: bone morphogenic protein 7; heparin; a Wnt agonist; retinoic acid; and an RA antagonist under conditions that promote formation of vascularized renal organoids. Another embodiment includes producing mesoderm cells by sequentially contacting pluripotent stem cells with a Wnt agonist and fibroblast growth factor 9 and/or fibroblast growth factor 20 and/or fibroblast growth factor 2, followed by a relatively short re-exposure to the Wnt agonist. The renal organoids may have end uses such as for kidney repair and regeneration, bioprinting of kidneys or functional components thereof, renal cell arrays and screening compounds for nephrotoxicity.
-
公开(公告)号:US20240400502A1
公开(公告)日:2024-12-05
申请号:US18540743
申请日:2023-12-14
Applicant: THE UNIVERSITY OF QUEENSLAND , The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Hol
Inventor: Luke O'NEILL , Rebecca Coll , Matthew Cooper , Avril Robertson , Kate Schroder
IPC: C07C311/56 , A61P1/00 , A61P3/00 , A61P5/00 , A61P17/00 , A61P25/00 , A61P35/00 , A61P37/00 , C07C311/60 , C07D207/38 , C07D213/71 , C07D215/36 , C07D217/02 , C07D217/22 , C07D217/24 , C07D221/18 , C07D231/18 , C07D235/02 , C07D241/24 , C07D241/42 , C07D241/44 , C07D249/04 , C07D249/06 , C07D249/12 , C07D261/18 , C07D271/12 , C07D277/36 , C07D307/18 , C07D307/64 , C07D307/68 , C07D307/82 , C07D309/08 , C07D311/16 , C07D311/18 , C07D311/60 , C07D317/62 , C07D333/34 , C07D333/52 , C07D333/62 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D413/12 , C07D417/12 , C07D487/04 , C07D493/04 , C07D495/04 , C07D495/06 , C07D498/04
Abstract: The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
-
公开(公告)号:US12116386B2
公开(公告)日:2024-10-15
申请号:US17573616
申请日:2022-01-11
Applicant: The University of Queensland
Inventor: Keith Joseph Chappell , Daniel Watterson , Paul Robert Young
CPC classification number: C07K14/16 , C07K19/00 , C12N15/1034 , C07K2317/55 , C07K2319/35 , C12N2740/16122 , C12N2740/16134 , C12N2760/10022 , C12N2760/10034 , C12N2760/14022 , C12N2760/14034 , C12N2760/16122 , C12N2760/16134 , C12N2760/18022 , C12N2760/18034 , C12N2770/20022 , C12N2770/20034
Abstract: Disclosed are chimeric polypeptides based on viral membrane fusion proteins. More particularly, the present invention discloses chimeric polypeptides that comprise a virion surface exposed portion of a viral fusion protein and a heterologous structure-stabilizing moiety, and to complexes of those chimeric polypeptides. The present invention also discloses the use of these complexes in compositions and methods for eliciting an immune response to a fusion protein of an enveloped virus, or complex of the fusion protein, and/or for treating or preventing an enveloped virus infection. The present invention further discloses the use of the heterologous structure-stabilizing moiety for oligomerizing heterologous molecules of interest.
-
公开(公告)号:US11980974B2
公开(公告)日:2024-05-14
申请号:US17294379
申请日:2019-10-31
Applicant: NIHON SUPERIOR CO., LTD. , The University of Queensland
Inventor: Kazuhiro Nogita , Stuart David Mcdonald , Shiqian Liu , Tetsuro Nishimura , Takatoshi Nishimura , Tetsuya Akaiwa
Abstract: In a method for manufacturing a solder joint part, at least one of a first metal base material and a second metal base material is an alloy containing Ni in an amount of more than 0 wt % and less than 44 wt % and Cu in an amount of more than 56 wt %, and solder is a solder alloy containing Ga and inevitable impurities or a solder alloy containing Ga as a main component and having a melting point of 30° C. or lower. The method includes applying the solder to a surface of the first metal base material and placing the second metal base material on the applied solder, and heating the first and second metal base materials to a temperature of 90° C. or lower in a specified atmosphere or in a liquid to generate CuGa2 or (Cu, Ni)Ga2 between the first and second metal base materials, thereby joining the first and second metal material.
-
公开(公告)号:US20240109847A1
公开(公告)日:2024-04-04
申请号:US18259052
申请日:2021-12-23
Applicant: THE UNIVERSITY OF QUEENSLAND
Inventor: David FAIRLIE , Ligong LIU , Robert REID , Jeffrey MAK
IPC: C07D239/91 , C07D231/56
CPC classification number: C07D239/91 , C07D231/56
Abstract: The present application is directed towards compounds, pharmaceutically acceptable salts or prodrugs thereof, which are inhibitors of Histone Deacetylase (HDAC) binding or function. The compounds especially may have some selectivity for inhibiting Class IIa versus Class I HDACs. The present application also relates to methods of using the compounds and to uses of the compounds, especially in relation to the prevention of a disease, disorder or condition associated with Class IIa HDAC activity. In one form, the compounds are (ortho-phenyl) phenyl hydroxamates. In another form, the compounds are as provided in Formula (I), wherein R1 is a phenyl or cycloalkenyl which may be optionally substituted. Formula (I)
-
公开(公告)号:US20240033343A1
公开(公告)日:2024-02-01
申请号:US18023136
申请日:2021-08-26
Applicant: THE UNIVERSITY OF QUEENSLAND
Inventor: Keith CHAPPELL , Paul YOUNG , Daniel WATTERSON
IPC: A61K39/215 , C07K14/005 , A61P31/14
CPC classification number: A61K39/215 , C07K14/005 , A61P31/14 , C12N2770/20034 , C12N2770/20022 , C07K2319/73 , C07K2319/91 , A61K2039/575
Abstract: This disclosure relates generally to modified SARS-CoV-2 spike polypeptides. More particularly, the present disclosure relates to modified SARS-CoV-2 spike proteins with improved properties, to chimeric polypeptides comprising these modified proteins, and to complexes comprising the chimeric polypeptides. The present disclosure also relates to the use of these modified polypeptides, chimeric polypeptides and complexes in compositions and methods for eliciting an immune response to ACE2-interacting coronaviruses, including SARS-CoV-2, and/or for treating or inhibiting the development of ACE2-interacting coronaviruses infections.
-
公开(公告)号:US20240027346A1
公开(公告)日:2024-01-25
申请号:US18253308
申请日:2021-11-17
Applicant: THE UNIVERSITY OF QUEENSLAND
Inventor: Paul Leslie BURN , Paul Edward SHAW , Shengqiang FAN
IPC: G01N21/64 , G01N31/22 , C07F7/18 , C07D235/18
CPC classification number: G01N21/6428 , G01N31/223 , C07F7/1804 , C07D235/18 , G01N2021/6439
Abstract: The disclosure relates to a method for detecting a nerve agent in an analyte, said nerve agent having a phosphorus-fluorine bond, which method comprises: (a) contacting the analyte with a solid state composition comprising a sensor compound; wherein the sensor compound comprises a basic nitrogen atom and a hydroxyaryl moiety protected by a silyl protecting group; and wherein, in the presence of hydrogen fluoride, said silyl group is cleaved to effect deprotection of the hydroxyl group thus forming a luminescent reporter compound; (b) irradiating the solid state composition at a predetermined wavelength; (c) measuring the luminescence to determine if the reporter compound is present; and (d) determining whether the nerve agent is present in the analyte based on the measurement obtained in step (c).
-
公开(公告)号:US11845715B2
公开(公告)日:2023-12-19
申请号:US17405989
申请日:2021-08-18
Applicant: THE UNIVERSITY OF QUEENSLAND , THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Inventor: Luke O'Neill , Rebecca Coll , Matthew Cooper , Avril Robertson , Kate Schroder
IPC: C07C311/56 , A61P17/00 , C07D403/12 , C07D249/12 , C07D249/04 , C07D241/42 , A61P25/00 , A61P37/00 , C07D495/04 , C07D241/44 , C07D277/36 , C07D307/68 , C07D487/04 , C07D215/36 , C07D249/06 , C07D311/16 , C07D401/06 , C07D401/12 , A61P3/00 , C07C311/60 , C07D213/71 , C07D217/22 , C07D221/18 , C07D317/62 , C07D333/34 , A61P1/00 , A61P35/00 , C07D217/02 , C07D241/24 , C07D271/12 , C07D413/12 , C07D417/12 , A61P5/00 , C07D307/18 , C07D307/64 , C07D311/60 , C07D333/52 , C07D333/62 , C07D405/12 , C07D495/06 , C07D217/24 , C07D235/02 , C07D311/18 , C07D407/12 , C07D231/18 , C07D307/82 , C07D309/08 , C07D493/04 , C07D207/38 , C07D261/18 , C07D498/04
CPC classification number: C07C311/56 , A61P1/00 , A61P3/00 , A61P5/00 , A61P17/00 , A61P25/00 , A61P35/00 , A61P37/00 , C07C311/60 , C07D207/38 , C07D213/71 , C07D215/36 , C07D217/02 , C07D217/22 , C07D217/24 , C07D221/18 , C07D231/18 , C07D235/02 , C07D241/24 , C07D241/42 , C07D241/44 , C07D249/04 , C07D249/06 , C07D249/12 , C07D261/18 , C07D271/12 , C07D277/36 , C07D307/18 , C07D307/64 , C07D307/68 , C07D307/82 , C07D309/08 , C07D311/16 , C07D311/18 , C07D311/60 , C07D317/62 , C07D333/34 , C07D333/52 , C07D333/62 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D413/12 , C07D417/12 , C07D487/04 , C07D493/04 , C07D495/04 , C07D495/06 , C07D498/04 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/16 , C07C2602/08 , C07C2602/10 , C07C2603/10
Abstract: The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
-
公开(公告)号:US11766409B2
公开(公告)日:2023-09-26
申请号:US17059770
申请日:2019-05-31
Applicant: THE UNIVERSITY OF QUEENSLAND
Inventor: Chunxia Zhao , Yun Liu
IPC: A61K31/137 , A61K9/51 , A61K47/69 , A61K31/12 , A61K31/135 , A61K31/192 , A61K31/337 , A61K31/7048 , A61K45/06 , B82Y5/00 , B82Y40/00
CPC classification number: A61K9/5192 , A61K9/5146 , A61K31/12 , A61K31/135 , A61K31/192 , A61K31/337 , A61K31/7048 , A61K45/06 , A61K47/6937 , B82Y5/00 , B82Y40/00
Abstract: A method of forming a core-shell polymer nanoparticle encapsulating an active agent is disclosed, including the use of a multi-solvent system in which to dissolve the active agent and a polymer prior to their precipitation using an antisolvent. The preferred use of an organic solvent system comprising two or more organic solvents allows for a high degree of control, as compared with the use of a single solvent, and enables the active agent to be precipitated more or less simultaneously with, or just prior to, the polymer.
-
公开(公告)号:US20230091569A1
公开(公告)日:2023-03-23
申请号:US17795824
申请日:2021-01-27
Applicant: THE UNIVERSITY OF QUEENSLAND
Inventor: Yongjun PENG , Xumeng CHEN
Abstract: An apparatus (40) for deaerating a froth comprising a spinning basket (44) mounted on a driven shaft (46). The side walls of the spinning basket have a mesh or openings therein. Froth is supplied to the interior of the spinning basket and contacts the floor of the spinning basket and is flung outwardly through the mesh or openings to break the bubbles and deaerate the froth. A solid all (42) may surround the spinning basket to further assist in deaeration. A spinning plate may be used in place of the spinning basket. In another embodiment, vacuum is used to deaerate the froth.
-
-
-
-
-
-
-
-
-